Cosmos Health Inc. (NASDAQ:COSM) Sees Large Growth in Short Interest

Cosmos Health Inc. (NASDAQ:COSM) was the recipient of a large increase in short interest during the month of June. As of June 30th, there was short interest totaling 4,744,953 shares, an increase of 102.5% from the June 15th total of 2,343,632 shares. Based on an average daily volume of 15,984,868 shares, the days-to-cover ratio is presently 0.3 days. Approximately 10.3% of the shares of the stock are short sold.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Cosmos Health in a research report on Monday, June 15th. One analyst has rated the stock with a Sell rating, According to MarketBeat, the company has an average rating of “Sell”.

Cosmos Health Trading Down 5.2%

NASDAQ:COSM traded down $0.02 during trading hours on Wednesday, hitting $0.29. The company had a trading volume of 4,132,757 shares, compared to its average volume of 4,609,426. Cosmos Health has a 1 year low of $0.16 and a 1 year high of $1.32. The company has a market cap of $18.06 million, a P/E ratio of -0.45 and a beta of 4.83. The company has a 50-day moving average of $0.25 and a 200 day moving average of $0.35. The company has a current ratio of 1.08, a quick ratio of 0.92 and a debt-to-equity ratio of 0.31.

Cosmos Health (NASDAQ:COSM) last announced its quarterly earnings results on Wednesday, May 20th. The company reported ($0.06) earnings per share for the quarter, meeting the consensus estimate of ($0.06). Cosmos Health had a negative net margin of 30.41% and a negative return on equity of 52.85%. The firm had revenue of $18.40 million for the quarter, compared to analysts’ expectations of $17.93 million. Sell-side analysts expect that Cosmos Health will post -0.06 earnings per share for the current year.

Insider Buying and Selling at Cosmos Health

In other Cosmos Health news, CFO Georgios Terzis bought 168,135 shares of the company’s stock in a transaction dated Tuesday, June 16th. The stock was acquired at an average price of $0.25 per share, with a total value of $42,033.75. Following the completion of the acquisition, the chief financial officer directly owned 2,235,398 shares of the company’s stock, valued at $558,849.50. This represents a 8.13% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Grigorios Siokas bought 701,447 shares of the company’s stock in a transaction dated Wednesday, June 10th. The shares were acquired at an average cost of $0.23 per share, with a total value of $161,332.81. Following the acquisition, the chief executive officer directly owned 13,263,361 shares of the company’s stock, valued at approximately $3,050,573.03. This represents a 5.58% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last three months, insiders purchased 1,088,029 shares of company stock valued at $249,240. 26.15% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Cosmos Health

Institutional investors and hedge funds have recently bought and sold shares of the company. XTX Topco Ltd lifted its holdings in Cosmos Health by 52.1% in the fourth quarter. XTX Topco Ltd now owns 99,610 shares of the company’s stock valued at $50,000 after acquiring an additional 34,117 shares during the last quarter. Renaissance Technologies LLC increased its stake in Cosmos Health by 16.7% during the first quarter. Renaissance Technologies LLC now owns 390,500 shares of the company’s stock worth $124,000 after acquiring an additional 55,925 shares during the last quarter. Finally, Citadel Advisors LLC raised its position in Cosmos Health by 133.1% in the third quarter. Citadel Advisors LLC now owns 225,507 shares of the company’s stock valued at $250,000 after purchasing an additional 128,776 shares during the period. 12.61% of the stock is currently owned by institutional investors and hedge funds.

Cosmos Health Company Profile

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.